ALDO-DHF & Paramount

por ElGuindy, Ahmed M
Publicado 2013

TOPCAT misses its primary endpoint: Should spironolactone be abandoned in HFpEF?

por ElGuindy, Ahmed M.
Publicado 2013

HEAT-PPCI: A clear and welcome win for heparin

por ElGuindy, Ahmed M.
Publicado 2014

STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era

por ElGuindy, Ahmed M.
Publicado 2014

STREAM at one year: Further evidence supporting a pharmacoinvasive strategy in patients with STEMI

por ElGuindy, Ahmed M.
Publicado 2015

FAME 2: Reshaping the approach to patients with stable coronary artery disease

por ElGuindy, Ahmed M.
Publicado 2015

PCI versus CABG in patients with complex coronary artery disease: Time for reconciliation?

por ElGuindy, Ahmed M, Afifi, Ahmed
Publicado 2013

FAME 2 – The best initial strategy for patients with stable coronary artery disease: Do we have an answer at last?

por ElGuindy, Ahmed M, Bonow, Robert O
Publicado 2013

BLOCK-HF: CRT gains new ground

por ElGuindy, Ahmed M., ElMaghawry, Mohamed
Publicado 2013

PARADIGM-HF: Have we achieved a new paradigm in the treatment of heart failure?

por Bonow, Robert O., ElGuindy, Ahmed M.
Publicado 2014

Aneurysmal coronary artery disease: An overview

por ElGuindy, Mohamed S., ElGuindy, Ahmed M.
Publicado 2017

NaNog: A pluripotency homeobox (master) molecule

por Allouba, Mona H., ElGuindy, Ahmed M., Krishnamoorthy, Navaneethakrishnan, Yacoub, Magdi H., Aguib, Yasmine E.
Publicado 2015